Larimar Therapeutics
LRMR
#8139
Rank
A$0.49 B
Marketcap
A$4.74
Share price
-2.48%
Change (1 day)
-13.94%
Change (1 year)

Earnings for Larimar Therapeutics (LRMR)

Earnings in 2026 (TTM): -A$0.26 Billion

According to Larimar Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$0.26 Billion a decrease over its 2024 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Larimar Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.26 Billion2.16%
2025 -A$0.26 Billion105.54%
2024 -A$0.13 Billion118.15%
2023 -A$55.83 Million4.51%
2022 -A$53.42 Million-30.18%
2021 -A$76.51 Million19.19%
2020 -A$64.19 Million